nystatin-a1 and Myasthenia-Gravis

nystatin-a1 has been researched along with Myasthenia-Gravis* in 1 studies

Other Studies

1 other study(ies) available for nystatin-a1 and Myasthenia-Gravis

ArticleYear
Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis.
    Zeitschrift fur Gerontologie und Geriatrie, 2011, Volume: 44, Issue:4

    An 85-year-old man with myasthenia gravis was successfully treated with methotrexate (10 mg/week), pyridostigmine and prednisolone (0-30 mg/day) for over 10 years. Then, he developed dysphagia and lost weight. Gastroscopy revealed Candida esophagitis. The patient received nystatin for 2 weeks. Methotrexate was stopped, and immunosuppressive therapy was continued with prednisolone alone. The patient has now remained in good condition for over 1 year. Although dysphagia is a typical symptom of myasthenia gravis, swallowing disturbances should not be attributed hastily to this disease, since they may also be a complication of therapy.

    Topics: Aged; Antifungal Agents; Candidiasis; Deglutition Disorders; Diagnosis, Differential; Drug Therapy, Combination; Esophagitis; Gastroscopy; Humans; Immunosuppressive Agents; Male; Methotrexate; Myasthenia Gravis; Nystatin; Prednisolone; Pyridostigmine Bromide

2011